Litchfield Hills Research Weighs in on NextPlat Q2 Earnings

NextPlat Corp. (NASDAQ:NXPL) – Litchfield Hills Research issued their Q2 2026 earnings per share estimates for shares of NextPlat in a report released on Wednesday, June 24th. Litchfield Hills Research analyst T. O’neill forecasts that the company will earn ($0.21) per share for the quarter. Litchfield Hills Research currently has a “Buy” rating and a $11.00 target price on the stock. Litchfield Hills Research also issued estimates for NextPlat’s Q3 2026 earnings at $0.00 EPS, Q4 2026 earnings at $0.07 EPS, FY2026 earnings at ($0.55) EPS, Q1 2027 earnings at $0.10 EPS, Q2 2027 earnings at $0.14 EPS, Q3 2027 earnings at $0.16 EPS, Q4 2027 earnings at $0.17 EPS and FY2027 earnings at $0.57 EPS.

NextPlat (NASDAQ:NXPL) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.42) EPS for the quarter. The firm had revenue of $9.86 million during the quarter. NextPlat had a negative net margin of 23.14% and a negative return on equity of 58.05%.

Separately, Weiss Ratings upgraded NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, NextPlat has an average rating of “Hold” and a consensus target price of $11.00.

NextPlat Stock Up 3.0%

NextPlat stock opened at $6.67 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.56 and a quick ratio of 2.12. NextPlat has a fifty-two week low of $3.38 and a fifty-two week high of $11.10. The firm has a fifty day moving average price of $6.37 and a two-hundred day moving average price of $5.93. The firm has a market cap of $18.09 million, a price-to-earnings ratio of -1.55 and a beta of 1.90.

Institutional Trading of NextPlat

An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new position in NextPlat Corp. (NASDAQ:NXPL) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat at the end of the most recent reporting period. 1.30% of the stock is owned by institutional investors and hedge funds.

More NextPlat News

Here are the key news stories impacting NextPlat this week:

• Positive Sentiment: Litchfield Hills Research initiated coverage on NextPlat Corp. (NXPL) with a Buy rating and a $11.00 price target, signaling confidence in upside potential. Street Insider article
• Positive Sentiment: The analyst’s estimates for FY2027 call for $0.57 EPS, suggesting NextPlat could move into profitability over the longer term. Benzinga article
• Neutral Sentiment: Short interest fell in mid-June, but the latest update showed an unusual zero-share figure, so the signal is unclear and likely has limited immediate impact.
• Neutral Sentiment: The research note also includes mixed near-term EPS estimates, including a projected loss in FY2026, which tempers the bullish outlook.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.